+629.1%
MRNA vs VO
+143.4%
+485.7%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | VO | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -0.8% | -2.5% | -2.7% |
| 7D | -10.1% | -0.6% | -9.5% | -9.7% |
| 30D | +126.7% | -1.9% | +128.7% | +130.4% |
| 3M | +184.1% | +3.3% | +180.9% | +177.8% |
| 6M | +143.3% | +9.7% | +133.6% | +127.7% |
| YTD | +359.9% | +12.6% | +347.2% | +323.8% |
| 1Y | +454.2% | +13.6% | +440.5% | +409.8% |
| 3Y | +26.0% | +56.8% | -30.8% | -3.9% |
| 5Y | -70.3% | +42.3% | -112.5% | -76.5% |
| All | +629.1% | +143.4% | +485.7% | +386.6% |
Cumulative growth
Daily Returns
Daily percentage return beside VO.
Daily Out/Under-Performance
Portfolio return minus VO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded VO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling